Terms: = Lung cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692
96 results:
1. Cytotoxic Programming of CD4+ T Cells Is Regulated by Opposing Actions of the Related Transcription Factors Eos and Aiolos.
Jones DM; Tuazon JA; Read KA; Leonard MR; Pokhrel S; Sreekumar BK; Warren RT; Yount JS; Collins PL; Oestreich KJ
J Immunol; 2024 Apr; 212(7):1129-1141. PubMed ID: 38363226
[TBL] [Abstract] [Full Text] [Related]
2. ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapy.
Li J; Meng Z; Cao Z; Lu W; Yang Y; Li Z; Lu S
Front Immunol; 2024; 15():1304183. PubMed ID: 38343549
[TBL] [Abstract] [Full Text] [Related]
3. Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma.
Liang J; Bi G; Sui Q; Zhao G; Zhang H; Bian Y; Chen Z; Huang Y; Xi J; Shi Y; Wang Q; Zhan C
Cell Rep; 2024 Feb; 43(2):113771. PubMed ID: 38335093
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer analysis of homeodomain-containing gene C10 and its carcinogenesis in lung adenocarcinoma.
Tan X; Li Z; Xie H; Chen J; Xiao J; Zhi Y; Mo H; Huang Y; Liu A
Aging (Albany NY); 2023 Dec; 15(24):15243-15266. PubMed ID: 38154103
[TBL] [Abstract] [Full Text] [Related]
5. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC).
Mukherjee O; Paul S; Das S; Rakshit S; Shanmugam G; George M; Sarkar K
Pathol Res Pract; 2024 Jan; 253():155004. PubMed ID: 38086291
[TBL] [Abstract] [Full Text] [Related]
6. SOCS2 inhibits hepatoblastoma metastasis via downregulation of the JAK2/stat5 signal pathway.
Lv Y; Xie X; Zou G; Kong M; Yang J; Chen J; Xiang B
Sci Rep; 2023 Dec; 13(1):21814. PubMed ID: 38071211
[TBL] [Abstract] [Full Text] [Related]
7. Anticancer Effects of 6-Gingerol through Downregulating Iron Transport and PD-L1 Expression in Non-Small Cell lung cancer Cells.
Kang DY; Park S; Song KS; Bae SW; Lee JS; Jang KJ; Park YM
Cells; 2023 Nov; 12(22):. PubMed ID: 37998363
[TBL] [Abstract] [Full Text] [Related]
8. lung cancer treatment potential and limits associated with the STAT family of transcription factors.
Faida P; Attiogbe MKI; Majeed U; Zhao J; Qu L; Fan D
Cell Signal; 2023 Sep; 109():110797. PubMed ID: 37423343
[TBL] [Abstract] [Full Text] [Related]
9. Expression and prognostic role of stat5a across cancer types.
Maninang C; Li J; Li WX
Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37369132
[TBL] [Abstract] [Full Text] [Related]
10. Identifying potential targets for lung cancer intervention by analyzing the crosstalk of cancer-associated fibroblasts and immune and metabolism microenvironment.
Wei S; Bao M; Zhu Y; Zhang W; Jiang L
Environ Toxicol; 2023 Aug; 38(8):1951-1967. PubMed ID: 37186041
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Value of EMT Gene Signature in Malignant Mesothelioma.
Wu L; Yoshihara K; Yun H; Karim S; Shokri N; Zaeimi F; Man HSJ; Zia A; Felley-Bosco E; de Perrot M
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901697
[TBL] [Abstract] [Full Text] [Related]
12. Mortality and lung function decline in patients who develop chronic pulmonary aspergillosis after lung cancer surgery.
Kim BG; Choi YS; Shin SH; Lee K; Um SW; Kim H; Jeon YJ; Lee J; Cho JH; Kim HK; Kim J; Shim YM; Jeong BH
BMC Pulm Med; 2022 Nov; 22(1):436. PubMed ID: 36418999
[TBL] [Abstract] [Full Text] [Related]
13. EGF promotes PKM2 O-GlcNAcylation by stimulating O-GlcNAc transferase phosphorylation at Y976 and their subsequent association.
Wang Y; Shu H; Liu J; Jin X; Wang L; Qu Y; Xia M; Peng P; Feng Y; Wei M
J Biol Chem; 2022 Sep; 298(9):102340. PubMed ID: 35931120
[TBL] [Abstract] [Full Text] [Related]
14. Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target.
Wadood A; Ajmal A; Junaid M; Rehman AU; Uddin R; Azam SS; Khan AZ; Ali A
Curr Pharm Des; 2022; 28(36):3023-3032. PubMed ID: 35909285
[TBL] [Abstract] [Full Text] [Related]
15. JAK-STAT core cancer pathway: An integrative cancer interactome analysis.
Erdogan F; Radu TB; Orlova A; Qadree AK; de Araujo ED; Israelian J; Valent P; Mustjoki SM; Herling M; Moriggl R; Gunning PT
J Cell Mol Med; 2022 Apr; 26(7):2049-2062. PubMed ID: 35229974
[TBL] [Abstract] [Full Text] [Related]
16. Prolactin is Expressed in Uterine Leiomyomas and Promotes Signaling and Fibrosis in Myometrial Cells.
DiMauro A; Seger C; Minor B; Amitrano AM; Okeke I; Taya M; Rackow AR; Kumar D; Kottman RM; Bhagavath B; Hammes SR
Reprod Sci; 2022 Sep; 29(9):2525-2535. PubMed ID: 34724171
[TBL] [Abstract] [Full Text] [Related]
17. Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell lung cancer (NSCLC) Cells.
Rugamba A; Kang DY; Sp N; Jo ES; Lee JM; Bae SW; Jang KJ
Cells; 2021 Jun; 10(7):. PubMed ID: 34209829
[TBL] [Abstract] [Full Text] [Related]
18. Th17/Treg-Related Intracellular Signaling in Patients with Chronic Obstructive Pulmonary Disease: Comparison between Local and Systemic Responses.
Lourenço JD; Teodoro WR; Barbeiro DF; Velosa APP; Silva LEF; Kohler JB; Moreira AR; Aun MV; da Silva IC; Fernandes FLA; Negri EM; Gross JL; Tibério IFLC; Ito JT; Lopes FDTQS
Cells; 2021 Jun; 10(7):. PubMed ID: 34206428
[TBL] [Abstract] [Full Text] [Related]
19. EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation.
Li Y; Li Y; Zhang H; Shi R; Zhang Z; Liu H; Chen J
BMC Pulm Med; 2021 Jun; 21(1):190. PubMed ID: 34090412
[TBL] [Abstract] [Full Text] [Related]
20. Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinib.
Dent P; Booth L; Poklepovic A; Von Hoff D; Martinez J; Zhou Y; Hancock JF
Biochem Pharmacol; 2021 Aug; 190():114642. PubMed ID: 34077739
[TBL] [Abstract] [Full Text] [Related]
[Next]
